Project OASIS: Optimizing Approaches to Select Implementation Strategies

Part of paid clinical trials in Pittsburgh, Pennsylvania.

Sponsor
VA Office of Research and Development
Study ID
NCT06061328
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • OASIS DA training — BEHAVIORAL
    The OASIS decision aid is a novel implementation strategy selection tool developed by a multidisciplinary team of experts using machine learning algorithms and user-centered design approaches.
  • Current DA Tool training — BEHAVIORAL
    The CFIR-ERIC Matching Tool is a currently available decision aid tool for selecting implementation strategies that is based on expert opinion.

Study Details

Barriers that prevent healthcare methods supported by science from being adopted in the real world have led to low-quality, inequitable medical care. Implementation science aims to bridge the evidence-to-practice gap but still lacks simple and convenient methods to identify implementation barriers, systematically track which strategies work to improve care, and provide accessible data and expert recommendations to guide implementation strategy selection for use in research and practice. Project OASIS (Optimizing Approaches to Select Implementation Strategies) will conduct a hybrid type-III, cluster-randomized trial of a new decision aid tool that matches site variables and barriers to successful implementation strategies.

Key Dates

Start date
Feb 1, 2024
Status verified
Feb 2026
Primary completion
Oct 31, 2027
Completion
Oct 31, 2027

Study Design

Enrollment
8,020 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: OASIS DA
    Half of the sites will be randomized to receive training on the OASIS decision aid.
  • Active Comparator: Current DA Tool
    Half of the sites will be randomized to receive training on the current decision aid tool.

Primary Outcome Measure

Reach as assessed by hepatocellular carcinoma (HCC) screening rates [ Time Frame: measured quarterly 1 year pre-intervention through 6 months post-intervention ]

Locations (1)

FacilityCityStateZIPSite coordinators
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PAPittsburghPennsylvania15240-

Find similar trials in Pittsburgh, PA

By condition
Liver cancer
By specialty
OncologyGI oncologyHepatology
By research site
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA· Pittsburgh, PA

Related Studies